Summary: This new French study assesses two definitions of 'clinically definite benign multiple sclerosis' (CDBMS) using long-term follow-up data, and to look for prognostic factors of CDBMS. The authors find that by either of two definitions of CDBMS, between 40-60% of patients would deteriorate on subsequent follow up and accrue disability leading the authors to conclude that CDBMS, as currently defined, is an “unwarranted conceptual hodgepodge”, and that more reliable biomarkers should be developed to identify patients with benign MS.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... pageid/722